Medexus Pharmaceuticals is Growing Fast, EBITDA Positive: Capital Ideas TV

Capital Ideas publisher Mark Bunting speaks with Medexus Pharmaceuticals Inc. (TSXV:MDP) CEO Ken d’Entremont


SmallCapPower partner Capital Ideas presents a special segment of Capital Ideas TV. In this episode, Mark Bunting, President and Publisher of Capital Ideas Media, talks with Ken d’Entremont, CEO of Medexus Pharmaceuticals Inc. (TSXV:MDP), to find out about the Company’s model of licensing existing drugs, its fast-growing revenue and operating profit, and how close the firm is to making a transformational deal using its $27 million in cash. Investors have a compelling, low-risk, specialty pharmaceutical company under their noses they may not know about.

To read our full disclosure, please click on the button below: